WO1994016681A1 - Composition de vaccin sous unitaire recombinant vivant et procede de preparation - Google Patents
Composition de vaccin sous unitaire recombinant vivant et procede de preparation Download PDFInfo
- Publication number
- WO1994016681A1 WO1994016681A1 PCT/FR1994/000106 FR9400106W WO9416681A1 WO 1994016681 A1 WO1994016681 A1 WO 1994016681A1 FR 9400106 W FR9400106 W FR 9400106W WO 9416681 A1 WO9416681 A1 WO 9416681A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition according
- virus
- recombinant
- vaccine
- montanide isa
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6516761A JPH08505866A (ja) | 1993-01-29 | 1994-01-28 | 組換えサブユニット生ワクチン組成物及びその製造方法 |
CA002154902A CA2154902A1 (fr) | 1993-01-29 | 1994-01-28 | Composition de vaccin sous unitaire recombinant vivant et procede de preparation |
EP94905751A EP0681470B1 (fr) | 1993-01-29 | 1994-01-28 | Composition de vaccin sous unitaire recombinant vivant et procede de preparation |
DE69400312T DE69400312T2 (de) | 1993-01-29 | 1994-01-28 | Zusammensetzung bestehend aus einem rekombinanten lebenden untereinheitsimpfstoff und verfahren zur herstellung |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR93/00942 | 1993-01-29 | ||
FR9300942A FR2700957B1 (fr) | 1993-01-29 | 1993-01-29 | Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994016681A1 true WO1994016681A1 (fr) | 1994-08-04 |
Family
ID=9443503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1994/000106 WO1994016681A1 (fr) | 1993-01-29 | 1994-01-28 | Composition de vaccin sous unitaire recombinant vivant et procede de preparation |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0681470B1 (fr) |
JP (2) | JPH08505866A (fr) |
CA (1) | CA2154902A1 (fr) |
DE (1) | DE69400312T2 (fr) |
DK (1) | DK0681470T3 (fr) |
ES (1) | ES2089923T3 (fr) |
FR (1) | FR2700957B1 (fr) |
WO (1) | WO1994016681A1 (fr) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995025542A1 (fr) * | 1994-03-22 | 1995-09-28 | Societe D'exploitation De Produits Pour L'industrie Chimique, S.E.P.P.I.C. | Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et medicament |
WO1996040956A1 (fr) * | 1995-06-07 | 1996-12-19 | American Home Products Corporation | Vaccins de recombinaison contre l'immunodeficience feline produits dans un baculovirus |
FR2754182A1 (fr) * | 1996-10-07 | 1998-04-10 | Seppic Sa | Nouvelles compositions vaccinales comportant comme adjuvant un compose sympathomimetique |
FR2754715A1 (fr) * | 1996-10-18 | 1998-04-24 | Seppic Sa | Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant |
US5817253A (en) * | 1993-07-22 | 1998-10-06 | Chemoxal, S.A. | Process for the treatment of an article and a new aqueous hydrogen peroxide solution |
US6117432A (en) * | 1995-04-20 | 2000-09-12 | Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) | Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
EP1095662A1 (fr) | 1999-10-29 | 2001-05-02 | Societe D'exploitation De Produits Pour Les Industries Chimiques, S.E.P.P.I.C. | Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite |
FR2809961A1 (fr) * | 2000-06-09 | 2001-12-14 | Seppic Sa | Utilisation d'ethers de sucres, comme adjuvants d'immunite dans les compositions vaccinales, compositions therapeutiques les renfermant et leur utilisation comme vaccins |
WO2002006305A1 (fr) * | 2000-07-17 | 2002-01-24 | Institute Of Immunology Co., Ltd. | Procede permettant de recueillir l'enveloppe virale d'un baculovirus |
WO2002062381A1 (fr) * | 2001-02-05 | 2002-08-15 | Hisamitsu Pharmaceutical Co., Inc. | Vaccin a vecteur de baculovirus |
WO2003009868A1 (fr) * | 2001-07-26 | 2003-02-06 | Otago Innovation Limited | Compositions antigeniques |
US6713068B1 (en) * | 1998-03-03 | 2004-03-30 | Merial | Live recombined vaccines injected with adjuvant |
EP1741785A1 (fr) | 1997-10-03 | 2007-01-10 | Merial | Circovirus porcins, acides nucléiques, polypeptides et vaccins |
AU2008202282B2 (en) * | 2001-07-26 | 2009-07-23 | Agresearch Limited | Immunogenic Compositions |
US9795565B2 (en) | 2007-10-24 | 2017-10-24 | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC | Method for preparing a vaccine composition comprising at least one antigen and at least one adjuvant |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2814956B1 (fr) * | 2000-10-06 | 2003-01-24 | Seppic Sa | Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation |
WO2003020322A1 (fr) * | 2001-09-04 | 2003-03-13 | DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung | Vecteur d'induction d'une reponse immune |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0129923A1 (fr) * | 1983-06-06 | 1985-01-02 | Duphar International Research B.V | Méthode pour la préparation de vaccins vivants adjuvés et les vaccins vivants adjuvés ainsi obtenus |
WO1991000107A1 (fr) * | 1989-07-03 | 1991-01-10 | Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) | Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable |
WO1992011028A1 (fr) * | 1990-12-19 | 1992-07-09 | Epitope, Inc. | Vaccin a transcriptase inverse contre le vih |
-
1993
- 1993-01-29 FR FR9300942A patent/FR2700957B1/fr not_active Expired - Fee Related
-
1994
- 1994-01-28 DE DE69400312T patent/DE69400312T2/de not_active Expired - Fee Related
- 1994-01-28 WO PCT/FR1994/000106 patent/WO1994016681A1/fr active IP Right Grant
- 1994-01-28 JP JP6516761A patent/JPH08505866A/ja not_active Ceased
- 1994-01-28 ES ES94905751T patent/ES2089923T3/es not_active Expired - Lifetime
- 1994-01-28 CA CA002154902A patent/CA2154902A1/fr not_active Abandoned
- 1994-01-28 EP EP94905751A patent/EP0681470B1/fr not_active Expired - Lifetime
- 1994-01-28 DK DK94905751.7T patent/DK0681470T3/da active
-
2003
- 2003-11-27 JP JP2003396681A patent/JP2004137283A/ja not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0129923A1 (fr) * | 1983-06-06 | 1985-01-02 | Duphar International Research B.V | Méthode pour la préparation de vaccins vivants adjuvés et les vaccins vivants adjuvés ainsi obtenus |
WO1991000107A1 (fr) * | 1989-07-03 | 1991-01-10 | Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) | Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable |
WO1992011028A1 (fr) * | 1990-12-19 | 1992-07-09 | Epitope, Inc. | Vaccin a transcriptase inverse contre le vih |
Non-Patent Citations (5)
Title |
---|
A. ADAM: "SYNTHETIC ADJUVANTS", 1985, JOHN WILEY & SONS, NEW YORK, N.Y., US * |
D.J. EVANS ET AL.: "AN ENGINEERED POLIOVIRUS CHIMAERA ELICITS BROADLY REACTIVE HIV-1 NEUTRALIZING ANTIBODIES.", NATURE., vol. 339, 1 June 1989 (1989-06-01), LONDON GB, pages 385 - 388 * |
H.P.A. HUGHES ET AL.: "MULTIPLE ADMINISTRATION WITH INTERLEUKIN-2 POTENTIATES ANTIGEN-SPECIFIC RESPONSES TO SUBUNIT VACCINATION WITH BOVINE HERPESVIRUS-1 GLYCOPROTEIN IV.", VACCINE, vol. 10, no. 4, 1992, GUILDFORD GB, pages 226 - 230 * |
M. ELOIT ET AL.: "CONSTRUCTION OF A DEFECTIVE ADENOVIRUS VECTOR EXPRESSING THE PSEUDORABIES VIRUS GLYCOPROTEIN gp50 AND ITS USE AS A LIVE VACCINE.", JOURNAL OF GENERAL VIROLOGY, vol. 71, no. 10, October 1990 (1990-10-01), READING, GB, pages 2425 - 2431 * |
See also references of EP0681470A1 * |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5817253A (en) * | 1993-07-22 | 1998-10-06 | Chemoxal, S.A. | Process for the treatment of an article and a new aqueous hydrogen peroxide solution |
WO1995025542A1 (fr) * | 1994-03-22 | 1995-09-28 | Societe D'exploitation De Produits Pour L'industrie Chimique, S.E.P.P.I.C. | Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et medicament |
US5801157A (en) * | 1994-03-22 | 1998-09-01 | Societe D'exploitation De Produits Pour L'industrie Chimique S.E.P.P.I.C. | Composition comprising a recombinant plasmid and its uses as vaccine and medicament |
US6117432A (en) * | 1995-04-20 | 2000-09-12 | Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) | Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
WO1996040956A1 (fr) * | 1995-06-07 | 1996-12-19 | American Home Products Corporation | Vaccins de recombinaison contre l'immunodeficience feline produits dans un baculovirus |
WO1996040957A1 (fr) * | 1995-06-07 | 1996-12-19 | American Home Products Corporation | Vaccins recombinants contre l'immunodeficience feline produits dans un baculovirus |
US5849303A (en) * | 1995-06-07 | 1998-12-15 | American Home Products Corporation | Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection |
FR2754182A1 (fr) * | 1996-10-07 | 1998-04-10 | Seppic Sa | Nouvelles compositions vaccinales comportant comme adjuvant un compose sympathomimetique |
WO1998015288A1 (fr) * | 1996-10-07 | 1998-04-16 | Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic | Composition vaccinale comportant comme adjuvant un compose sympathomimetique |
FR2754715A1 (fr) * | 1996-10-18 | 1998-04-24 | Seppic Sa | Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant |
WO1998017311A1 (fr) * | 1996-10-18 | 1998-04-30 | Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic | Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant |
EP1741785A1 (fr) | 1997-10-03 | 2007-01-10 | Merial | Circovirus porcins, acides nucléiques, polypeptides et vaccins |
US6713068B1 (en) * | 1998-03-03 | 2004-03-30 | Merial | Live recombined vaccines injected with adjuvant |
US7507416B2 (en) | 1998-03-03 | 2009-03-24 | Merial Limited | Live recombined vaccines injected with adjuvant |
EP1058558B1 (fr) * | 1998-03-03 | 2005-01-26 | Merial | Vaccins recombinants et adjuvés contre le virus de l'influenza et le virus de l'herpès |
EP1095662A1 (fr) | 1999-10-29 | 2001-05-02 | Societe D'exploitation De Produits Pour Les Industries Chimiques, S.E.P.P.I.C. | Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite |
EP1163909A3 (fr) * | 2000-06-09 | 2002-02-06 | Societe D'exploitation De Produits Pour Les Industries Chimiques-Seppic | Utilisation d'éthers de sucres, comme adjuvants d'immunité dans les compositions vaccinales, compositions thérapeutiques les renfermant et leur utilisation comme vaccins |
EP1163909A2 (fr) * | 2000-06-09 | 2001-12-19 | Societe D'exploitation De Produits Pour Les Industries Chimiques-Seppic | Utilisation d'éthers de sucres, comme adjuvants d'immunité dans les compositions vaccinales, compositions thérapeutiques les renfermant et leur utilisation comme vaccins |
FR2809961A1 (fr) * | 2000-06-09 | 2001-12-14 | Seppic Sa | Utilisation d'ethers de sucres, comme adjuvants d'immunite dans les compositions vaccinales, compositions therapeutiques les renfermant et leur utilisation comme vaccins |
WO2002006305A1 (fr) * | 2000-07-17 | 2002-01-24 | Institute Of Immunology Co., Ltd. | Procede permettant de recueillir l'enveloppe virale d'un baculovirus |
WO2002062381A1 (fr) * | 2001-02-05 | 2002-08-15 | Hisamitsu Pharmaceutical Co., Inc. | Vaccin a vecteur de baculovirus |
WO2003009868A1 (fr) * | 2001-07-26 | 2003-02-06 | Otago Innovation Limited | Compositions antigeniques |
AU2008202282B2 (en) * | 2001-07-26 | 2009-07-23 | Agresearch Limited | Immunogenic Compositions |
AU2008202282B8 (en) * | 2001-07-26 | 2009-08-13 | Agresearch Limited | Immunogenic Compositions |
US7758869B2 (en) | 2001-07-26 | 2010-07-20 | Immune Solutions Limited | Immunogenic compositions |
US9795565B2 (en) | 2007-10-24 | 2017-10-24 | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC | Method for preparing a vaccine composition comprising at least one antigen and at least one adjuvant |
Also Published As
Publication number | Publication date |
---|---|
ES2089923T3 (es) | 1996-10-01 |
CA2154902A1 (fr) | 1994-08-04 |
DE69400312T2 (de) | 1996-11-21 |
JP2004137283A (ja) | 2004-05-13 |
EP0681470B1 (fr) | 1996-07-17 |
DK0681470T3 (da) | 1996-08-12 |
DE69400312D1 (de) | 1996-08-22 |
EP0681470A1 (fr) | 1995-11-15 |
FR2700957B1 (fr) | 1995-03-03 |
JPH08505866A (ja) | 1996-06-25 |
FR2700957A1 (fr) | 1994-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0681470B1 (fr) | Composition de vaccin sous unitaire recombinant vivant et procede de preparation | |
EP0480982B1 (fr) | Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable | |
EP0825875B1 (fr) | Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines | |
EP1976560B1 (fr) | Emulsion huile dans eau thermoreversible | |
EP0639071A1 (fr) | Emulsions vaccinales fluides eau-dans-l'huile contenant une huile metabolisable | |
EP0751788B1 (fr) | Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et medicament | |
FR2800280A1 (fr) | Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite | |
FR2754715A1 (fr) | Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant | |
FR2814956A1 (fr) | Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation | |
FR2754182A1 (fr) | Nouvelles compositions vaccinales comportant comme adjuvant un compose sympathomimetique | |
EP1163909B1 (fr) | Utilisation d'éthers de sucres, comme adjuvants d'immunité dans les compositions vaccinales, compositions thérapeutiques les renfermant et leur utilisation comme vaccins | |
EP1385475A2 (fr) | Adjuvant d'immunite contenant un cation metallique complexe et vaccin le contenant | |
EP1397122B1 (fr) | Adjuvant d'immunité sous forme solide et vaccin le contenant | |
EP1387669A1 (fr) | Emulsion e/h concentree | |
WO2011092412A1 (fr) | Utilisation d'une huile minerale specifique pour la fabrication d'un nouveau adjuvant | |
FR2824269A1 (fr) | Composition adjuvante constituee de 1% a 15% de tensioactifs a hlb global compris entre 5 et 8 et de 85% a 99% de corps gras | |
FR2888117A1 (fr) | Composition vaccinale comprenant une emulsion thermoreversible |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1994905751 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2154902 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 1995 500919 Country of ref document: US Date of ref document: 19950731 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 1994905751 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1994905751 Country of ref document: EP |